Tolerability and Efficacy of Apixaban Versus Rivaroxaban for Non-Valvular Atrial Fibrillation. mfm [Internet]. 2022 Apr. 7 [cited 2026 Oct. 12];33(3). Available from: http://medicalforummonthly.com/index.php/mfm/article/view/586